β-Blocker Treatment May Not Reduce Risks One Year After Myocardial Infarction
Beta-blocker treatment beyond 1year after myocardial infarction not linked to improved cardiovascular outcomes.
Beta-blocker treatment beyond 1year after myocardial infarction not linked to improved cardiovascular outcomes.
Sex differences seen for coronary-related and noncardiac hospitalizations in year following discharge.
The phase 3 trial included 13,970 adults who were unable to maximize or tolerate a statin and had, or were at high risk for, cardiovascular disease.
Patients with gout flare have increased odds of cardiovascular events, independent of traditional cardiovascular risk factors.
A healthy patient presents with an unusual cause of cardiogenic shock following a night of alcohol drinking and marijuana use.
These recommendations only apply to individuals who do not have a history of CVD and are not already taking daily aspirin.
A team of researchers sought to evaluate the incidence of and factors contributing to cognitive dysfunction among individuals having experienced myocardial infarction.
The authors describe how to diagnose and treat comorbid cardiogenic shock and COVID-19 in this case study.
Starting aspirin in patients 60 years or older to prevent a first heart attack or stroke is not recommended.
New referral protocol that incorporates AMI READMITS assessment tools improved the referral process for patients with type-1 myocardial infarction.